Tazorax 1.125 Injection
Marketer
Leeford Healthcare Ltd
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Tazorax 1.125 Injection
Combithrox 1.125 Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, curbing infection spread. Administration must be under a physician's direct guidance; strict adherence to the prescribed schedule is crucial. Complete the entire treatment course, regardless of symptom improvement; premature cessation may compromise efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening side effects warrant immediate medical attention. Seek immediate medical help for allergic reactions (rash, pruritus, edema, dyspnea). Inform your physician of all concurrent medications, including those for pre-existing conditions. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and sufficient hydration promote faster recovery. Monitoring the medication's effects may involve supplementary laboratory tests at your doctor's discretion.
Uses of Tazorax 1.125 Injection
Infections caused by bacteria
Major Benefits of Tazorax 1.125 Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Tazorax 1.125 Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Tazorax 1.125 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Tazorax 1.125 Injection works:
Ceftriaxone and Tazobactam, the components of Tazorax 1.125 Injection, act synergistically. Ceftriaxone, an antibiotic, disrupts bacterial cell wall synthesis, crucial for bacterial viability. Tazobactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby optimizing Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Tazorax 1.125 Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The use of Tazorax 1.125 Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for the fetus; nevertheless, data from human studies are scarce.
Breast feedingCAUTION
Administering Tazorax 1.125 Injection to breastfeeding mothers requires careful consideration. It's advised to discontinue breastfeeding throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Tazorax 1.125 Injection might reduce attentiveness, impair vision, and induce drowsiness or dizziness. Refrain from driving if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Data on Tazorax 1.125 Injection's use in individuals with renal impairment is scarce. Physician consultation is recommended.
LiverCAUTION
Individuals with severe hepatic impairment should use Tazorax 1.125 Injection cautiously, potentially requiring dosage modification. Consult a physician for guidance. Dosage alteration for Tazorax 1.125 Injection is unnecessary in those with mild to moderate liver dysfunction.
What if you forget to take Tazorax 1.125 Injection :
Omitting a scheduled Tazorax 1.125 Injection requires contacting your physician.
Facts to Know About Tazorax 1.125 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
3,018 People bought this recently